Opinion

Video

Updates in Treatment Approaches With CDK4/6 Inhibitors in HR+ Breast Cancer

A panel of experts discuss treatment updates in regards to CDK4/6 inhibitors.

Related Videos
3 KOLs are featured in this series.
3 KOLs are featured in this series.
Andrew Davis, MD
Adrienne G. Waks, MD, Dana-Farber Cancer Institute
Video 8 - 2 KOLs are featured in, "Emerging Trials in the Management of HR+/HER2- mBC"
Video 7 - 2 KOLs are featured in, "Adverse Event Data and Management for Optimal Quality of Life in HR+/HER2- mBC"
4 KOLs are featured in this series
4 KOLs are featured in this series
4 KOLs are featured in this series